ISN Webinar: C3G – Biopsy interpretation, monoclonal gammopathy, and complement inhibition

This webinar will provide a focused update on key diagnostic and management considerations in C3 glomerulopathy (C3G). Expert speakers will explore the role of kidney biopsy in C3G, discuss monoclonal gammopathy of renal significance (MGRS), and review upcoming C3G guidelines and their potential implications for clinical practice.

Learning objectives:

- Review the role of kidney biopsy in the diagnosis and evaluation of  C3G.
- Discuss the recognition and clinical significance of monoclonal  gammopathy of renal significance and its relationship to C3G.
- Explore upcoming C3G guidelines and consider how evolving  recommendations may inform patient management.

This webinar is supported by Novartis